Evidence map›Paper›PMID 28794686›Full record

ArticleTropical medicine and health2017

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.

Rispah T Sawe, Simeon K Mining, Ayub V Ofulla, Kirtika Patel, Bernard Guyah, David Chumba, Jenifer R Prosperi, Maggie Kerper, Zonggao Shi, Mayra Sandoval-Cooper and 4 more

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Rispah T SaweDepartment of Immunology, Moi University, College of Health Sciences, School of Medicine, P.O.Box 4606-30100, Eldoret, Kenya.
Simeon K MiningDepartment of Immunology, Moi University, College of Health Sciences, School of Medicine, P.O.Box 4606-30100, Eldoret, Kenya.
Ayub V OfullaDepartment of Biomedical Sciences, School of Public Health and Community Development, Maseno University, Kisumu, Kenya.
Kirtika PatelDepartment of Immunology, Moi University, College of Health Sciences, School of Medicine, P.O.Box 4606-30100, Eldoret, Kenya.
Bernard GuyahDepartment of Biomedical Sciences, School of Public Health and Community Development, Maseno University, Kisumu, Kenya.
David ChumbaDepartment of Immunology, Moi University, College of Health Sciences, School of Medicine, P.O.Box 4606-30100, Eldoret, Kenya.
Jenifer R ProsperiUniversity of Notre Dame, Notre Dame, IN USA.
Maggie KerperUniversity of Notre Dame, Notre Dame, IN USA.
Zonggao ShiUniversity of Notre Dame, Notre Dame, IN USA.
Mayra Sandoval-CooperUniversity of Notre Dame, Notre Dame, IN USA.
Katherine TaylorUniversity of Notre Dame, Notre Dame, IN USA.
Sunil BadveHarper Cancer Research Institute, South Bend, 46617 IN USA.
M Sharon StackUniversity of Notre Dame, Notre Dame, IN USA.
Laurie E LittlepageUniversity of Notre Dame, Notre Dame, IN USA.
University of Notre Dame · USMaseno University · KEMoi University · KEIndiana University School of Medicine

Funding

Online Raman Diagnostics of OncometabolitesR33CA206922 · NCI · UNIVERSITY OF NOTRE DAME · PI SCHULTZ, ZACHARY · 2016 to 2018
$1.0M
NCI NIH HHS R33 CA206922
6 · The paper itself

Abstract

backgroundTumors commonly are infiltrated by leukocytes, or tumor infiltrating leukocytes (TILs). It remains unclear, however, if the density and type of individual TILs has a direct or simply correlative role in promoting poor prognosis in breast cancer patients. Breast cancer in Kenyan women is aggressive with presentation at a young age, with advanced grade (grade III), large tumor size (>2.0 cm), and poor prognosis. We previously observed that the tumors were predominantly estrogen receptor positive (ER+) but also included both a high percentage of triple negative tumors and also increased immune cell infiltration within the tumors. We used breast tumor tissues from each patient to make tissue microarrays that were then stained for leukocyte and myeloid markers including CD4, CD8, CD20, CD25, CD68, and CD163 using immunohistochemical techniques. The immune cell infiltration into the cancer tissue included increased numbers of macrophages (CD68+), helper T cells (CD4+), and CD25+ lymphocytes compared to benign tissue.

resultsThis study characterized the grade, molecular subtypes, and proliferation index of these tumors and determined if TIL density was enriched across any of these factors. We analyzed 49 malignant patient tissue samples for this study. The patient population had a mean age of 51.9 years. The tumors analyzed were heterogeneous by grade: grade I (6%), grade II (47%), and grade III (39%). Most patients presented with large tumors (>2.0 cm) (69%). We classified the tumors into molecular subtypes based on clinical marker expression. Based on this analysis, the molecular subtype distribution was heterogeneous with luminal B (41%), basal/triple negative (TN) (37%), luminal A (14%) and HER2 (8%) breast cancer subtypes. While the basal/TN subtype had a much higher proliferative index (Ki-67+) than did the other molecular subtypes, we did not see a significant correlation between TIL density and either subtype or tumor grade. Therefore, TIL density is independent of molecular subtype and grade.

conclusionThis study identified a Kenyan patient cohort that develops large, high-grade tumors primarily of the luminal B and basal molecular subtypes. After analyzing the TILs within these tumors, we found that immune cell infiltration of these tumors correlated with increased proliferation but not grade or molecular subtype. Future research is required to determine if the aberrant recruitment of TILs to tumors contributes to cancer progression and response to cancer treatments.

Indexed as

AdvancedAfricanAggressive breast cancerBreast cancer subtypesKenyanTumor infiltrating leukocytes (TILs)

Identifiers

PMID28794686
PMCPMC5543450
OpenAlexW2736079077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.